title: Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern.
authors.forename: Gloria
authors.initials: G
authors.lastname: Vergara
authors.forename: Juan Francisco
authors.initials: JF
authors.lastname: Silvestre
authors.forename: Isabel
authors.initials: I
authors.lastname: Betlloch
authors.forename: Paloma
authors.initials: P
authors.lastname: Vela
authors.forename: María Pilar
authors.initials: MP
authors.lastname: Albares
authors.forename: José Carlos
authors.initials: JC
authors.lastname: Pascual
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001707:Biopsy, Needle; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D011379:Prognosis; D018570:Risk Assessment
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab